OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/22/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization31,480 mln
Float1,819 mln
Earnings Date05/11/2026
EPS
0.89
Moderate
P / E
18.50
Moderately valued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.19
Caution advised
Relative Strength
47
/ 100
In line with market
Debt / Equity
0.18
Very low leverage
Business Description
Daiichi Sankyo is a Japanese pharmaceutical company founded in 1899 and headquartered in Tokyo, with operations across the United States, Europe, and other markets worldwide. The company develops and sells a broad range of medicines covering cancer, heart disease, diabetes, bone health, pain, and neurological conditions, along with vaccines for illnesses such as influenza and COVID-19. Among its best-known products are Enhertu, a cancer treatment targeting HER2-positive tumors, and several widely used medications for high blood pressure, high cholesterol, and blood clotting. The company also works with outside partners to advance research and bring new treatments to patients faster.
